about
Combining biochemical and imaging markers to improve diagnosis and characterization of mild traumatic brain injury in the acute setting: results from a pilot studyCorrection: Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics AssessmentCharacterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics AssessmentGlutamine treatment attenuates the development of ischaemia/reperfusion injury of the gutEpidemiology and clinical characteristics of traumatic brain injury in Lebanon: A systematic review.Generalized versus partial reflex seizures: a review.Assessing neuro-systemic & behavioral components in the pathophysiology of blast-related brain injury.Minor and repetitive head injury.Data comparison between pharmacological induction of labour and spontaneous delivery. A single centre experience.Complications of trauma patients admitted to the ICU in level I academic trauma centers in the United States.Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review.Genotoxic effects of anesthetic agents: an update.Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention.αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.CSF and plasma amyloid-β temporal profiles and relationships with neurological status and mortality after severe traumatic brain injuryUbiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizureEmerging markers of cachexia predict survival in cancer patients.Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology?Blood-based diagnostics of traumatic brain injuries.Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluidsHuman traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products.Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury ConditionsNeuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury.Thyroxine transfer from cerebrospinal fluid into choroid plexus and brain is affected by brefeldin A, low sodium, BCH, and phloretin, in ventriculo-cisternal perfused rabbits.Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk.Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator.Exploratory study of serum ubiquitin carboxyl-terminal esterase L1 and glial fibrillary acidic protein for outcome prognostication after pediatric cardiac arrest.Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients.Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain InjuryDeciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment.Neuroprotective effect of preoperatively induced mild hypothermia as determined by biomarkers and histopathological estimation in a rat subdural hematoma decompression modelUtility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.Neuroproteomics and Systems Biology Approach to Identify Temporal Biomarker Changes Post Experimental Traumatic Brain Injury in Rats.Post-genomics nanotechnology is gaining momentum: nanoproteomics and applications in life sciences.Renal complications in oncohematologic patients.Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury.Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literature.
P50
Q28535264-B0EBC809-160B-48F1-8EBD-CF2D27E1F20DQ28547349-F8CDA8AE-8E15-4020-9D77-C67117CB6F7AQ28547909-EE0935BA-B607-46FB-8688-496BED660270Q28581945-4090F6FF-838D-4036-B979-4902E2D42A39Q30239763-2247B675-F7C2-4DF6-82A0-E6B55A8AE21AQ30361725-58680B27-89A1-41A9-B2AE-9527E5E61E6EQ30446201-419E7FCA-88AB-4FF4-A774-0CD735C0F8D9Q30870662-6737141F-BF4C-4417-9F00-C33158BBFAD9Q31148489-2B5CF120-459D-406A-916A-F518F479A4D2Q33786980-57133025-B3DE-44BA-9341-C0CC4D60D71EQ33863821-7A9CBC19-C32E-4839-AC88-FC9B1EE2B8A3Q33905781-365C9341-A53A-49A8-A71C-A9DD99F873CDQ33916315-8013C3B6-B4C6-4CA7-B570-D13DF39C2762Q34142573-ABE2AEB1-21A4-4408-8FD1-BC04E08964EFQ34318048-E1AAEA10-0B98-4F5C-AAE7-38518C8EDC66Q34397124-C2F98FA0-521B-40C5-8348-A524DA7F258FQ34551579-4C5D43C3-345C-4880-A2E9-125E86A9F931Q34629872-322063A4-EF39-4857-88E4-8336515A8E8DQ34714369-544E7DC3-B6AD-4CFC-8EF7-044CEF1281F3Q35040539-6C715548-7A30-4352-A516-E1A571C4C198Q35131093-88835496-F05C-4BBF-873F-AA4A92D08C6DQ35252148-646F51F8-07DF-48A8-8154-2B1241AAC079Q35558386-7893F58D-E0A0-46AB-86D3-0427F0C019FFQ35783757-CD408ECD-4C9F-46AE-A9DF-F4A52AD1689BQ35886747-F10B879B-4C24-4C43-B13A-657B7FD50C2BQ36101994-D316C8B4-7278-4B6F-B4DC-26205281E0B0Q36104689-6ADE630B-8B52-4830-A8D1-00CB21FE3959Q36131599-FBF03388-58EE-4280-B569-21A6A7BF2B08Q36689419-008521D3-D46E-4C1B-A090-165B715B69E9Q36796090-56742956-09A9-41E9-B561-CC4337164A0AQ37019440-9970D587-5783-4750-99FB-A367B4E7FDF8Q37132873-B01F35D8-3068-41C6-A9EF-043CA281F526Q37141680-5E08EFA5-0BE7-4080-AF79-C348E5772CECQ37240562-9DC8B4E7-A827-4550-964E-A60420A03D44Q37316677-12340C4A-EE8E-4AB0-AD51-54864E9B78FDQ37428030-A9DFCCC7-0D60-48E0-983A-C51B49BB84CAQ37577230-C93DD182-70C0-406F-9FC9-77B250A80A27Q37642548-A5FA8C4E-7E8D-4035-886B-93B1187160A7Q37651653-506B9422-BF44-493B-9F58-7DA6B9FE44A1Q37687106-FC543EDE-BF25-438D-9FDC-C060DB80E219
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Stefania Mondello
@ast
Stefania Mondello
@en
Stefania Mondello
@es
Stefania Mondello
@nl
Stefania Mondello
@sl
type
label
Stefania Mondello
@ast
Stefania Mondello
@en
Stefania Mondello
@es
Stefania Mondello
@nl
Stefania Mondello
@sl
prefLabel
Stefania Mondello
@ast
Stefania Mondello
@en
Stefania Mondello
@es
Stefania Mondello
@nl
Stefania Mondello
@sl
P1053
A-1813-2012
P106
P1153
23094881100
P1960
u_YXlbIAAAAJ
P21
P214
1675147907502479210001
P2798
P31
P3762
P3829
P496
0000-0002-8587-3614
P734
P735
P7859
lccn-nb2016020110